Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis.

Matsumoto, Kosuke; Hirohara, Junko; Takeuchi, Akihito; Miura, Ryo; Asaoka, Yoshinari; Nakano, Toshiaki; Tanaka, Atsushi

Matsumoto, Kosuke; Hirohara, Junko; Takeuchi, Akihito; Miura, Ryo; Asaoka, Yoshinari; Nakano, Toshiaki; Tanaka, Atsushi.

Afiliação

Matsumoto K; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Hirohara J; The Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Takeuchi A; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Miura R; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Asaoka Y; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Nakano T; The Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Tanaka A; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.

Hepatol Res ; 53(10): 989-997, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37291072

Palavras-chave

PBC; UDCA; fibrate; prognostic factors; transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google